Both FH535 treatment and β-catenin silencing strongly reduced MCP1 and MCP2 levels.<h4>Conclusion</h4>FH535 shows antitumor effects in colorectal cancer by blocking Wnt/β-catenin signaling. The gene discussed is CCL2; the disease is colorectal cancer.